Cognitive and Physical Functions in Patients With Transient Ischemic Attack. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active. One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care. And to identify if persons with TIA presents with cognitive impairments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 7, 2011
CompletedFirst Posted
Study publicly available on registry
January 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedSeptember 16, 2014
September 1, 2014
4.9 years
June 7, 2011
September 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Physical activity over time
Physical activity measured with accelerometer (Time frame: Baseline, 3, 6, and 12 month).
at discharge from hospital, 3, 6 and 12 month after the event
Secondary Outcomes (7)
Change in Cognition and Mental Fatigue
All measures at baseline 3, 6 and 12 month after the event
Change in 6 MWT
3, 6 and 12 months
Change in self reported stages of change
3, 6, 12 months
Change from baseline in systolic blood pressure at 12 months
3, 6, 12 months
BMI
12 months
- +2 more secondary outcomes
Study Arms (4)
Physical activity on Prescription (PaP)
EXPERIMENTALIntervention group receives a PaP for 12 month.
Control Group
NO INTERVENTIONThe control group has the same monitoring as the experimental group but receives no PaP.
Cognitiv function in patients with TIA
NO INTERVENTIONBefore discharged from hospital cognitive function is assessed. At the first visit the patients fill in a self assessment questionnaire for mental fatigue. If impaired at the previous assessment cognitive function will be assessed at 3, 6 and 12 month.
Controlgroup Cognitive function
NO INTERVENTIONIn order to determine whether hospitalization in itself is associated with transient impaired cognition, a comparison group will be included. The comparison group will consist of patients with angina pectoris consecutively admitted to the Norrtälje Hospital. The patients with angina pectoris will be age and sex matched with the patients with TIA and assessed for cognitive function when their angina symptoms have subsided.
Interventions
The advice on physical activity is patient oriented and based on FYSS (FYSS is a information bank that summarizes the up-to-date scientific knowledge on how to prevent and treat various diseases and conditions using physical activity). An individual prescription on physical activity is issued. The prescription form reminds of an ordinary drug prescription and provides specified types of physical activities including intensity, frequency and duration of the respective activities. The prescribed physical activity could be either self-monitored or organized by public physical activity organizations.
Eligibility Criteria
You may qualify if:
- Understand Swedish language (also in and writing), living in Norrtälje community,
- To participate in the assessment of cognitive function: no known cognitive impairments before the TIA event and history of stroke.
You may not qualify if:
- Presence of contraindications to exercise, and no history of stroke
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tiohundra ABlead
- Karolinska Institutetcollaborator
Study Sites (1)
Tiohundra
Norrtälje, Stockholms Läns Landsting, 76192, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Disa Sommerfeld
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 7, 2011
First Posted
January 13, 2012
Study Start
May 1, 2010
Primary Completion
April 1, 2015
Study Completion
July 1, 2015
Last Updated
September 16, 2014
Record last verified: 2014-09